Compare · CNCR vs DWMC

CNCR vs DWMC

Side-by-side comparison of Loncar Cancer Immunotherapy ETF (CNCR) and AdvisorShares Dorsey Wright Micro-Cap ETF (DWMC): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both CNCR and DWMC operate in n/a (n/a), so they compete in similar markets.
MetricCNCRDWMC
Company
Loncar Cancer Immunotherapy ETF
AdvisorShares Dorsey Wright Micro-Cap ETF
Price
-
-
Market cap
-
-
1M return
-
-
1Y return
-
-
Sector
n/a
n/a
Industry
n/a
n/a
Exchange
NASDAQ
NASDAQ
IPO
n/a
n/a
News (4w)
0
0
Recent ratings
0
0
CNCR

Loncar Cancer Immunotherapy ETF

The investment seeks to track the total return performance, before fees and expenses, of the Loncar Cancer Immunotherapy Index. The index is composed of the common stock of approximately 30 pharmaceutical or biotechnology companies identified by the fund's index provider, as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. The adviser attempts to invest all, or substantially all, of its assets in the component securities and ADRs that make up the index. Normally it will invest at least 80% of its total assets in the component securities of the index. The fund is non-diversified.

DWMC

AdvisorShares Dorsey Wright Micro-Cap ETF

The investment seeks long term capital appreciation. The fund is an actively-managed exchange-traded fund ("ETF") that seeks to achieve its investment objective by investing primarily in U.S.-traded equity securities consisting of common and preferred stock and American Depositary Receipts ("ADRs"). ADRs are securities traded on a local exchange stock exchange that represent interests in securities issued by a foreign publicly listed company. Under normal circumstances, the fund invests at least 80% of its net assets (plus any borrowings for investment purposes) in micro-cap securities.